Top

CardioVascular and Interventional Radiology

Published in:

01-08-2013 | Clinical Investigation

Transjugular Intrahepatic Portosystemic Shunt for Treatment of Cirrhosis-related Chylothorax and Chylous Ascites: Single-institution Retrospective Experience

Authors: Steven G. Kikolski, Hamed Aryafar, Steven C. Rose, Anne C. Roberts, Thomas B. Kinney

Published in: CardioVascular and Interventional Radiology | Issue 4/2013

Abstract

Purpose

To investigate the efficacy and safety of the use of transjugular intrahepatic portosystemic shunt (TIPS) creation to treat cirrhosis-related chylous collections (chylothorax and chylous ascites).

Methods

We retrospectively reviewed data from four patients treated for refractory cirrhosis-related chylous collections with TIPS at our institution over an 8 year period.

Results

One patient had chylothorax, and three patients had concomitant chylothorax and chylous ascites. There were no major complications, and the only procedure-related complications occurred in two patients who had mild, treatable hepatic encephalopathy. All patients had improvement as defined by decreased need for thoracentesis or paracentesis, with postprocedure follow-up ranging from 19 to 491 days.

Conclusion

TIPS is a safe procedure that is effective in the treatment of cirrhosis-related chylous collections.

Light RW (2007) Chylothorax and pseudochylothorax. In: Pleural diseases. Lippincott Williams & Wilkins, Philadelphia, pp 346–361

Romero S, Martín C, Hernandez L et al (1998) Chylothorax in cirrhosis of the liver: analysis of its frequency and clinical characteristics. Chest 114:154–159PubMedCrossRef

Maldonado F, Hawkins FJ, Daniels CE et al (2009) Pleural fluid characteristics of chylothorax. Mayo Clin Proc 84:129–133PubMedCrossRef

Doerr CH, Allen MS, Nichols FC et al (2005) Etiology of chylothorax in 203 patients. Mayo Clin Proc 80:867–870PubMedCrossRef

Staats BA, Ellefson RD, Budahn LL et al (1980) The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 55:700–704PubMed

Frick E, Scholmerich J (2005) Etiology, diagnosis, and management of non-cirrhotic ascites. In: Ginès P, Arroyo V, Rodes J, Schrier R (eds) Ascites and renal dysfunction in liver diseases: pathogenesis, diagnosis, and treatment. Blackwell Publishing, Oxford, pp 294–304CrossRef

Cárdenas A, Chopra S (2002) Chylous ascites. Am J Gastroenterol 97:1896–1900PubMed

Witte CL, Witte MH, Dumont AE (1980) Lymph imbalance in the genesis and perpetuation of the ascites syndrome in hepatic cirrhosis. Gastroenterology 78(5 pt 1):1059–1068PubMed

Witte MH, Dumont AE, Cole WR et al (1969) Lymph circulation in hepatic cirrhosis: effect of portacaval shunt. Ann Intern Med 70:303–310PubMedCrossRef

10.

Orloff MJ, Goodhead B, Windsor CW et al (1967) Effect of portacaval shunts on lymph flow in the thoracic duct. Experiments with normal dogs and dogs with cirrhosis and ascites. Am J Surg 114:213–221PubMedCrossRef

11.

Dumont AE, Witte MH (1996) Contrasting patterns of thoracic duct lymph formation in hepatic cirrhosis. Surg Gynecol Obstet 122:524–528

12.

Dumont AE, Mulholland JH (1962) Alterations in thoracic duct lymph flow in hepatic cirrhosis: significance in portal hypertension. Ann Surg 156:668–675PubMedCrossRef

13.

Dumont AE, Mulholland JH (1960) Flow rate and composition of thoracic-duct lymph in patients with cirrhosis. N Engl J Med 263:471–474PubMedCrossRef

14.

Rosser BG, Poterucha JJ, McKusick MA et al (1996) Thoracic duct–cutaneous fistula in a patient with cirrhosis of the liver: successful treatment with a transjugular intrahepatic portosystemic shunt. Mayo Clin Proc 71:793–796PubMedCrossRef

15.

Vignaux O, Gouya H, Dousset B et al (2002) Refractory chylothorax in hepatic cirrhosis: successful treatment by transjugular intrahepatic portosystemic shunt. J Thorac Imaging 17:233–236PubMedCrossRef

16.

de Vries GJ, Ryan BM, de Bièvre M et al (2005) Cirrhosis related chylous ascites successfully treated with TIPS. Eur J Gastroenterol Hepatol 17:463–466PubMedCrossRef

17.

Kinney TB, Ferrara SL, Miller FJ et al (2004) Transjugular intrahepatic portosystemic shunt creation as treatment for refractory chylous ascites and chylothorax in a patient with cirrhosis. J Vasc Interv Radiol 15(1 pt 1):85–89PubMedCrossRef

18.

Garcia N, Mihas AA (2004) Hepatic hydrothorax: pathophysiology, diagnosis, and management. J Clin Gastroenterol 38:52–58PubMedCrossRef

Title: Transjugular Intrahepatic Portosystemic Shunt for Treatment of Cirrhosis-related Chylothorax and Chylous Ascites: Single-institution Retrospective Experience
Authors: Steven G. Kikolski
Hamed Aryafar
Steven C. Rose
Anne C. Roberts
Thomas B. Kinney
Publication date: 01-08-2013
Publisher: Springer New York
Published in: CardioVascular and Interventional Radiology / Issue 4/2013
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-012-0530-x

At a glance: The STEP trials

Springer Medicine

Transjugular Intrahepatic Portosystemic Shunt for Treatment of Cirrhosis-related Chylothorax and Chylous Ascites: Single-institution Retrospective Experience

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2013

Endovascular Treatment of Pelvic Congestion Syndrome: Visual Analog Scale (VAS) Long-Term Follow-up Clinical Evaluation in 202 Patients

Recanalization of Acute and Subacute Venous and Synthetic Bypass-Graft Occlusions With a Mechanical Rotational Catheter

Bare Metal Stenting for Endovascular Exclusion of Aortic Arch Thrombi

Techniques for Intravascular Foreign Body Retrieval

The Changing Face of Vascular Interventional Radiology: The Future Role of Pharmacotherapies and Molecular Imaging

Central Venous Disease in Hemodialysis Patients: An Update